SPRY
ARS Pharma Sets Sights on Market Share Growth with Targeted Provider Commercial Execution
ARS Pharma, a leading pharmaceutical company, has outlined its strategic priorities for the next phase of growth during its Q2 2026 earnings conference call. Donn Casale, President and CEO, emphasized the importance of a disciplined operational approach in driving market share expansion. "Today marks a pivotal moment for ARS